The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(Biphenyl-4-ylmethyl)-5-bromo-1H-indole-2-sulfonamide ID: ALA4476181
PubChem CID: 66547074
Max Phase: Preclinical
Molecular Formula: C21H17BrN2O2S
Molecular Weight: 441.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(NCc1ccc(-c2ccccc2)cc1)c1cc2cc(Br)ccc2[nH]1
Standard InChI: InChI=1S/C21H17BrN2O2S/c22-19-10-11-20-18(12-19)13-21(24-20)27(25,26)23-14-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-13,23-24H,14H2
Standard InChI Key: BTSRRDYCHLMCRE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
34.2601 -6.2651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2643 -7.0823 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.9699 -6.6702 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.7671 -6.6902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7659 -7.5097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4740 -7.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4722 -6.2813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1808 -6.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1856 -7.5098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9700 -7.7596 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4500 -7.0908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9622 -6.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6800 -7.7912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4971 -7.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9099 -8.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5045 -9.2002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9166 -9.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7346 -9.9006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1389 -9.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7244 -8.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1491 -10.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7439 -11.3138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1569 -12.0181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9750 -12.0126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3782 -11.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9629 -10.5956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0593 -6.2818 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
11 2 1 0
2 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
18 21 1 0
4 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.35Molecular Weight (Monoisotopic): 440.0194AlogP: 5.08#Rotatable Bonds: 5Polar Surface Area: 61.96Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.66CX Basic pKa: ┄CX LogP: 5.13CX LogD: 5.13Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.45Np Likeness Score: -0.97
References 1. Greig IR, Baillie GL, Abdelrahman M, Trembleau L, Ross RA.. (2016) Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators., 26 (18): [PMID:27542310 ] [10.1016/j.bmcl.2016.08.018 ]